|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Genitourinary cancer
Clinical Outcomes of Small Cell Carcinoma of the Genitourinary Tra
ct
and the Prognostic Significance of the Tumor Immune Microenvironment
Jaewon Hyung, Hyung-Don Kim, Gi Hwan Kim, Yong Mee Cho, Yeon-Mi Ryu, Sang-Yeob Kim, Inkeun Park, Shinkyo Yoon, Jae Lyun Lee
Cancer Res Treat.
2024;56(2):624-633. Published online November 29, 2023 DOI:
https://doi.org/10.4143/crt.2023.1076
Physical A
ct
ivity and Bladder Cancer Risk: Findings of the Japan Collaborative Cohort Study
Hang An, Keyang Liu, Kokoro Shirai, Ryo Kawasaki, Akiko Tamakoshi, Hiroyasu Iso
Cancer Res Treat.
2024;56(2):616-623. Published online October 6, 2023 DOI:
https://doi.org/10.4143/crt.2023.962
Gastrointestinal cancer
A Single-Arm Phase II Study of Nab-Paclitaxel Plus Gemcitabine and Cisplatin for Locally Advanced or Metastatic Biliary Tra
ct
Cancer
Ting Liu, Qing Li, Zhen Lin, Chunhua Liu, Wei Pu, Shasha Zeng, Jun Lai, Xuebin Cai, Lisha Zhang, Shuyang Wang, Miao Chen, Wei Cao, Hongfeng Gou, Qing Zhu
Cancer Res Treat.
2024;56(2):602-615. Published online October 12, 2023 DOI:
https://doi.org/10.4143/crt.2023.726
Crossref 1
A Phase 1b/2a Study of GC1118 with 5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in Patients with Recurrent or Metastatic Colore
ct
al Cancer
Keun-Wook Lee, Sae-Won Han, Tae Won Kim, Joong Bae Ahn, Ji Yeon Baek, Sang Hee Cho, Howard Lee, Jin Won Kim, Ji-Won Kim, Tae-You Kim, Yong Sang Hong, Seung-Hoon Beom, Yongjun Cha, Yoonjung Choi, Seonhui Kim, Yung-Jue Bang
Cancer Res Treat.
2024;56(2):590-601. Published online December 7, 2023 DOI:
https://doi.org/10.4143/crt.2023.1117
Breast cancer
Genomic Chara
ct
eristics and Its Therapeutic Implications in Breast Cancer Patients with Dete
ct
able Molecular Residual Disease
Shu Zhang, Yan Jiang, Lu Zhou, Jing Xu, Gang Zhang, Lu Shen, Yan Xu
Cancer Res Treat.
2024;56(2):538-548. Published online December 5, 2023 DOI:
https://doi.org/10.4143/crt.2023.1059
Temporal Trend in Uptake of the National General Health Checkups and Cancer Screening Program among Korean Women with Breast Cancer
Thi Xuan Mai Tran, Soyeoun Kim, Chihwan Cha, Boyoung Park
Cancer Res Treat.
2024;56(2):522-530. Published online October 30, 2023 DOI:
https://doi.org/10.4143/crt.2023.729
General
Impa
ct
of Patient Sex on Adverse Events and Unscheduled Utilization of Medical Services in Cancer Patients Undergoing Adjuvant Chemotherapy: A Multicenter Retrospe
ct
ive Cohort Study
Songji Choi, Seyoung Seo, Ju Hyun Lee, Koung Jin Suh, Ji-Won Kim, Jin Won Kim, Se Hyun Kim, Yu Jung Kim, Keun-Wook Lee, Jwa Hoon Kim, Tae Won Kim, Yong Sang Hong, Sun Young Kim, Jeong Eun Kim, Sang-We Kim, Dae Ho Lee, Jae Cheol Lee, Chang-Min Choi, Shinkyo Yoon, Su-Jin Koh, Young Joo Min, Yongchel Ahn, Hwa Jung Kim, Jin Ho Baek, Sook Ryun Park, Jee Hyun Kim
Cancer Res Treat.
2024;56(2):404-413. Published online November 7, 2023 DOI:
https://doi.org/10.4143/crt.2023.784
Genitourinary cancer
Clear Cell Adenocarcinoma of Urethra: Clinical and Pathologic Implications and Chara
ct
erization of Molecular Aberrations
Boram Song, Seok Hyun Lee, Jeong Hwan Park, Kyung Chul Moon
Cancer Res Treat.
2024;56(1):280-293. Published online September 11, 2023 DOI:
https://doi.org/10.4143/crt.2023.577
Crossref 1
Gastrointestinal cancer
Risk Fa
ct
ors for Distant Metastasis in Extrahepatic Bile Du
ct
Cancer after Curative Rese
ct
ion (KROG 1814)
Younghee Park, Tae Hyun Kim, Kyubo Kim, Jeong Il Yu, Wonguen Jung, Jinsil Seong, Woo Chul Kim, Jin Hwa Choi, Ah Ram Chang, Bae Kwon Jeong, Byoung Hyuck Kim, Tae Gyu Kim, Jin Hee Kim, Hae Jin Park, Hyun Soo Shin, Jung Ho Im, Eui Kyu Chie
Cancer Res Treat.
2024;56(1):272-279. Published online July 31, 2023 DOI:
https://doi.org/10.4143/crt.2023.616
Risk Stratification of Pancreatic Du
ct
al Adenocarcinoma Patients Undergoing Curative-Intent Surgery after Neoadjuvant Therapy
Hyun Kyung Yang, Mi-Suk Park, Kyunghwa Han, Geonsik Eom, Yong Eun Chung, Jin-Young Choi, Seungmin Bang, Chang Moo Kang, Jinsil Seong, Myeong-Jin Kim
Cancer Res Treat.
2024;56(1):247-258. Published online August 22, 2023 DOI:
https://doi.org/10.4143/crt.2023.586
Association between Metabolically Healthy Status and Risk of Gastrointestinal Cancer
Haozhe Cui, Fei Tian, Yongliang Chen, Xiangming Ma
Cancer Res Treat.
2024;56(1):238-246. Published online August 2, 2023 DOI:
https://doi.org/10.4143/crt.2023.539
GASTric Cancer HER2 Re-Assessment Study 2 (GASTHER2): HER2 Re-assessment for Initially HER2-Negative Advanced Gastric Cancer Patients after Progression on First-Line Treatment
Jaewon Hyung, Hyung-Don Kim, Min-Hee Ryu, Young Soo Park, Meesun Moon, Yoon-Koo Kang
Cancer Res Treat.
2024;56(1):199-207. Published online June 20, 2023 DOI:
https://doi.org/10.4143/crt.2023.490
Fun
ct
ional Annotation and Gene Set Analysis of Gastric Cancer Risk Loci in a Korean Population
Hyojin Pyun, Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Joohon Sung, Jeongseon Kim
Cancer Res Treat.
2024;56(1):191-198. Published online June 20, 2023 DOI:
https://doi.org/10.4143/crt.2022.958
Breast cancer
Short-term Impa
ct
of Hormone Replacement Therapy on Risk of Breast Cancer in
BRCA
Mutation Carriers: A Nationwide Study in South Korea
Hye Yeon Kim, Jisoo Park, Seok Joo Moon, Sohyeon Jeong, Jin Hwa Hong, Jae Kwan Lee, Geum Joon Cho, Hyun-Woong Cho
Cancer Res Treat.
2024;56(1):143-148. Published online August 16, 2023 DOI:
https://doi.org/10.4143/crt.2023.653
Crossref 1
Impa
ct
of Social Support during Diagnosis and Treatment on Disease Progression in Young Patients with Breast Cancer: A Prospe
ct
ive Cohort Study
Danbee Kang, Seri Park, Hyo Jung Kim, Seok Won Kim, Jeong Eon Lee, Jonghan Yu, Se Kyung Lee, Ji-Yeon Kim, Seok Jin Nam, Juhee Cho, Yeon Hee Park
Cancer Res Treat.
2024;56(1):125-133. Published online September 4, 2023 DOI:
https://doi.org/10.4143/crt.2023.673
Lung and Thoracic cancer
Tumor Microenvironment Modulation by Neoadjuvant Erlotinib Therapy and Its Clinical Impa
ct
on Operable
EGFR
-Mutant Non–Small Cell Lung Cancer
Beung-Chul Ahn, Charny Park, Moon Soo Kim, Jong Mog Lee, Jin Ho Choi, Hyae Young Kim, Geon Kook Lee, Namhee Yu, Youngjoo Lee, Ji-Youn Han
Cancer Res Treat.
2024;56(1):70-80. Published online June 21, 2023 DOI:
https://doi.org/10.4143/crt.2023.482
First-Line Ale
ct
inib vs. Brigatinib in Advanced Non–Small Cell Lung Cancer with
ALK
Rearrangement: Real-World Data
Youngkyung Jeon, Sehhoon Park, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn
Cancer Res Treat.
2024;56(1):61-69. Published online July 14, 2023 DOI:
https://doi.org/10.4143/crt.2023.461
Crossref 1
Genitourinary cancer
TNM-Based Head-to-Head Comparison of Urachal Carcinoma and Urothelial Bladder Cancer: Stage-Matched Analysis of a Large Multicenter National Cohort
Sang Hun Song, Jaewon Lee, Young Hwii Ko, Jong Wook Kim, Seung Il Jung, Seok Ho Kang, Jinsung Park, Ho Kyung Seo, Hyung Joon Kim, Byong Chang Jeong, Tae-Hwan Kim, Se Young Choi, Jong Kil Nam, Ja Yoon Ku, Kwan Joong Joo, Won Sik Jang, Young Eun Yoon, Seok Joong Yun, Sung-Hoo Hong, Jong Jin Oh
Cancer Res Treat.
2023;55(4):1337-1345. Published online April 17, 2023 DOI:
https://doi.org/10.4143/crt.2023.417
Web of Science 2
Crossref 2
Favorable Immunotherapy Plus Tyrosine Kinase Inhibition Outcome of Renal Cell Carcinoma Patients with Low CDK5 Expression
Xianglai Xu, Ying Wang, Zhaoyi Chen, Yanjun Zhu, Jiajun Wang, Jianming Guo
Cancer Res Treat.
2023;55(4):1321-1336. Published online April 3, 2023 DOI:
https://doi.org/10.4143/crt.2022.1532
Gastrointestinal cancer
Analysis of Plasma Circulating Tumor DNA in Borderline Rese
ct
able Pancreatic Cancer Treated with Neoadjuvant Modified FOLFIRINOX: Clinical Relevance of DNA Damage Repair Gene Alteration Dete
ct
ion
Dong-Hoon Lim, Hyunseok Yoon, Kyu-pyo Kim, Baek-Yeol Ryoo, Sang Soo Lee, Do Hyun Park, Tae Jun Song, Dae Wook Hwang, Jae Hoon Lee, Ki Byung Song, Song Cheol Kim, Seung-Mo Hong, Jaewon Hyung, Changhoon Yoo
Cancer Res Treat.
2023;55(4):1313-1320. Published online May 4, 2023 DOI:
https://doi.org/10.4143/crt.2023.452
Web of Science 1
Crossref 3
Prevalence and Risk Fa
ct
ors of Germline Pathogenic Variants in Pancreatic Du
ct
al Adenocarcinoma
Kum Hei Ryu, Sunhwa Park, Jung Won Chun, Eunhae Cho, Jongmun Choi, Dong-Eun Lee, Hyoeun Shim, Yun-Hee Kim, Sung-Sik Han, Sang-Jae Park, Sang Myung Woo, Sun-Young Kong
Cancer Res Treat.
2023;55(4):1303-1312. Published online April 3, 2023 DOI:
https://doi.org/10.4143/crt.2023.291
Web of Science 1
Crossref 1
ARID1A
Mutation from Targeted Next-Generation Sequencing Predi
ct
s Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tra
ct
Cancer
Sung Hwan Lee, Jaekyung Cheon, Seoyoung Lee, Beodeul Kang, Chan Kim, Hyo Sup Shim, Young Nyun Park, Sanghoon Jung, Sung Hoon Choi, Hye Jin Choi, Choong-kun Lee, Hong Jae Chon
Cancer Res Treat.
2023;55(4):1291-1302. Published online May 3, 2023 DOI:
https://doi.org/10.4143/crt.2022.1450
Differential Perspe
ct
ives by Specialty on Oligometastatic Colore
ct
al Cancer: A Korean Oligometastasis Working Group’s Comparative Survey Study
Won Kyung Cho, Gyu Sang Yoo, Chai Hong Rim, Jae-Uk Jeong, Eui Kyu Chie, Yong Chan Ahn, Hyeon-Min Cho, Jun Won Um, Yang-Gun Suh, Ah Ram Chang, Jong Hoon Lee, On behalf of the Oligometastasis Working Group, Korean Cancer Association
Cancer Res Treat.
2023;55(4):1281-1290. Published online June 7, 2023 DOI:
https://doi.org/10.4143/crt.2023.479
Web of Science 2
Crossref 1
Specific Mutations in
APC
, with Prognostic Implications in Metastatic Colore
ct
al Cancer
Huan Peng, Jun Ying, Jia Zang, Hao Lu, Xiaokai Zhao, Pengmin Yang, Xintao Wang, Jieyi Li, Ziying Gong, Daoyun Zhang, Zhiguo Wang
Cancer Res Treat.
2023;55(4):1270-1280. Published online April 24, 2023 DOI:
https://doi.org/10.4143/crt.2023.415
Web of Science 2
Crossref 1
Clinical Significance of Combining Preoperative and Postoperative Albumin-Bilirubin Score in Colore
ct
al Cancer
Doyoun Kim, Jae-Hoon Lee, Eun-Suk Cho, Su-Jin Shin, Hye Sun Lee, Hwa-Hee Koh, Kang Young Lee, Jeonghyun Kang
Cancer Res Treat.
2023;55(4):1261-1269. Published online April 17, 2023 DOI:
https://doi.org/10.4143/crt.2022.1444
Web of Science 1
Crossref 1
Development and Validation of Models to Predi
ct
Lymph Node Metastasis in Early Gastric Cancer Using Logistic Regression and Gradient Boosting Machine Methods
Hae Dong Lee, Kyung Han Nam, Cheol Min Shin, Hye Seung Lee, Young Hoon Chang, Hyuk Yoon, Young Soo Park, Nayoung Kim, Dong Ho Lee, Sang-Hoon Ahn, Hyung-Ho Kim
Cancer Res Treat.
2023;55(4):1240-1249. Published online March 21, 2023 DOI:
https://doi.org/10.4143/crt.2022.1330
Web of Science 2
Crossref 2
The Role of Adjuvant Chemotherapy after Neoadjuvant Chemoradiotherapy Followed by Surgery in Patients with Esophageal Squamous Cell Carcinoma
Seong Yong Park, Hong Kwan Kim, Yeong Jeong Jeon, Junghee Lee, Jong Ho Cho, Yong Soo Choi, Young Mog Shim, Jae Il Zo
Cancer Res Treat.
2023;55(4):1231-1239. Published online April 24, 2023 DOI:
https://doi.org/10.4143/crt.2022.1417
Web of Science 3
Crossref 2
Lung and Thoracic cancer
Sublobar Rese
ct
ion versus Stereota
ct
ic Body Radiation Therapy for Clinical Stage I Non–Small Cell Lung Cancer: A Study Using Data from the Korean Nationwide Lung Cancer Registry
Jeonghee Yun, Jong Ho Cho, Tae Hee Hong, Kyungmi Yang, Yong Chan Ahn, Hong Kwan Kim, Korean Association for Lung Cancer, Korea Central Cancer Registry
Cancer Res Treat.
2023;55(4):1171-1180. Published online April 17, 2023 DOI:
https://doi.org/10.4143/crt.2022.1581
Final Report on Real-World Effe
ct
iveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non–Small Cell Lung Cancer: Updated Analysis of the RESET Study
Taeyun Kim, Tae Won Jang, Chang Min Choi, Mi-Hyun Kim, Sung Yong Lee, Yoon Soo Chang, Kye Young Lee, Seung Joon Kim, Sei Hoon Yang, Jeong Seon Ryu, Jeong Eun Lee, Shin Yup Lee, Chan Kwon Park, Sang Hoon Lee, Seung Hun Jang, Seong Hoon Yoon, Hyung-Joo Oh
Cancer Res Treat.
2023;55(4):1152-1170. Published online May 19, 2023 DOI:
https://doi.org/10.4143/crt.2023.493
Crossref 2
Head and Neck cancer
Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Hana Kim, Sehhoon Park, Hyun Ae Jung, Se-Hoon Lee, Keunchil Park, Yong Chan Ahn, Dongryul Oh, Myung-Ju Ahn
Cancer Res Treat.
2023;55(4):1104-1112. Published online May 17, 2023 DOI:
https://doi.org/10.4143/crt.2023.502
Web of Science 4
Crossref 5
1
2
3
4
5
6
7
8
9
10
Journal Impact Factor 4.6
> Browse Articles > Search
